The DOI matches its Crossref record; 17 of the 20 references it cites were found in a registry or an index; none of the 9 sources its claims cite is checked for support yet.
Hereditary tyrosinemia type I: Self-induced correction of the fumarylacetoacetase defect
Open accessAbstract
Two Norwegian patients with chronic tyrosinemia type I showed > 50% residual fumarylacetoacetase activity in liver samples obtained during liver transplantation. The enzyme characteristics of both patients were comparable with those of a normal control. Immunohistochemistry on liver sections from these patients and from three other Norwegian tyrosinemia patients revealed a mosaicism of fumarylacetoacetase immunoreactivity corresponding completely or partly to some of the regenerating nodules. This appearance of enzyme protein is presumably induced by the disease process. The mechanism involved remains unclear and could be caused by a genetic alteration, regained translation of messenger RNA, or to enhanced stability of an abnormal enzyme.
Overview
CoChat Summary
## TL;DR
This study reports unexpected residual fumarylacetoacetase (FAH) activity and mosaic FAH immunoreactivity in liver tissue from patients with hereditary tyrosinemia type I, suggesting self-induced correction of the enzyme defect in some hepatocyte clones. The authors argue that this mosaicism could make liver-biopsy-based diagnosis misleading in chronic cases.
## Key findings
- In two Norwegian patients with chronic tyrosinemia type I, frozen liver samples taken at transplantation showed substantial FAH activity: patient 1 had 6–32 U/g protein and patient 2 had 26 U/g protein, compared with 33–66 U/g protein in controls.
- Immunohistochemistry showed a mosaic pattern of FAH staining in regenerating nodules; in patient 2, one section showed FAH immunoreactivity in only two regenerating nodules, while another section from the same patient showed all nodules positive.
- Similar mosaic FAH staining was seen in the other studied tyrosinemia patients, including patient 4, and the authors state mosaicism was observed in patients 1, 3, and 5 as well.
- The FAH enzyme from patients 1 and 2 had Km, Vmax, pH optimum, inhibition pattern toward metal ions, and freeze/thaw stability comparable with a normal control, supporting the idea that the reexpressed enzyme was functionally normal.
## Methods
- The study examined five Norwegian tyrosinemia type I patients diagnosed at 1–6 years of age by low FAH activity in fibroblasts and/or lymphocytes plus elevated urinary succinylacetone.
- Liver tissue collected at transplantation was analyzed by FAH activity assays, Western blotting, subcellular fractionation (patient 2), and immunohistochemistry using the APAAP method on formalin-fixed paraffin-embedded sections.
- The authors compared enzyme kinetics and inhibitor sensitivity in patients 1 and 2 with a normal control, and also examined liver sections from normal controls and patients with cirrhosis from other causes.
## Limitations
- The paper does not identify the mechanism of correction; it explicitly says the mechanism remains unclear and could involve a genetic alteration, regained translation of mRNA, or enhanced stability of an abnormal enzyme.
- The findings are based on a small sample of five patients, with detailed biochemical characterization concentrated in two patients.
- Evident from the text: the study is observational and cannot determine causality for the mosaicism or prove which proposed mechanism is correct.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 1 Not valid · 6 Not checked · 18 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Two Norwegian patients with chronic tyrosinemia type I showed > 50% residual fumarylacetoacetase activity in liver samples obtained during liver transplantation.”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The three cirrhotic patients with either chronic active hepatitis (Fig. 4) or chronic autoimmune hepatitis had immunoreactive FAH protein in all regenerating nodules.”
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no apparent morphological difference between positive and negative hepatocytes (C and D) in this patient.”
hedgedSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunohistochemistry on liver sections from these patients and from three other Norwegian tyrosinemia patients revealed a mosaicism of fumarylacetoacetase immunoreactivity corresponding completely or partly to some of the regenerating nodules.”
- Also stated in: § Results · plain
“a distinct mosaic pattern of FAH with immunoreactivity confined to only two regeneration nodules was seen in one section (A), whereas in another section (B), all nodules were positive.”
- Also stated in: § Results · plain
“Mosaicism was observed also in the other three patients (1, 3, and 5); some sections showed mostly immunoreactive nodules while other areas were mainly negative.”
plainstates an associationn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The enzyme characteristics of both patients were comparable with those of a normal control.”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
10 more claims
Create a free account to see all 25 claims and every source verdict.
- Borderline: one of the tests for a substantial claim is unclear. 1
- Probably not a substantial claim. 4
- It may state two separate claims as one. 6
Citations
Cites
Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue
de Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., & Appelmans, F. (1955) · Biochemical Journal · doi:10.1042/bj0600604 · Cited by 4,174
Review and hypotheses: somatic mosaicism: observations related to clinical genetics.
Hall, J. G. (1988) · Europe PMC (PubMed Central) · Cited by 342
The occurrence of hepatoma in the chronic form of hereditary tyrosinemia
Weinberg, A. G., Mize, C. E., & Worthen, H. G. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)80259-4 · Cited by 283
Phaneuf, D., Labelle, Y., Bérubé, D., Arden, K. C., Cavenee, W. K., Gagné, R., & Tanguay, R. M. (1991) · Europe PMC (PubMed Central) · Cited by 121
Tanguay, R. M., Valet, J. P., Lescault, A., Duband, J., Laberge, C. M., Lettre, F., & Plante, M. (1990) · Europe PMC (PubMed Central) · Cited by 105
Grenier, A., Lescault, A., Laberge, C., Gagné, R., & Marner, O. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90117-6 · Cited by 73
Tyrosinaemia type I — an update
Kvittingen, E. A. (1991) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01797926 · Cited by 61
Self-citationKvittingen, E. A., Jellum, E., & Stokke, O. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90244-8 · Cited by 55
Self-citationBiochemical studies on the enzymatic deficiencies in hereditary tyrosinemia
Berger, R., van Faassen, H., & Smith, G. P. A. (1983) · Clinica Chimica Acta · doi:10.1016/0009-8981(83)90191-2 · Cited by 45
Self-citationStoner, E., Starkman, H. S., Wellner, D., Wellner, V. P., Sassa, S., Rifkind, A. B., Grenier, A., Steinherz, P. G., Meister, A., New, M. I., et al. (1984) · Pediatric Research · doi:10.1203/00006450-198412000-00023 · Cited by 43
Research works printed but not linked: 1
- [1]1. Goldsmith, L. A., and C. Laberge. 1989. Tyrosinemia and related disorders. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. -S. Sly, and D. Valle, editors. McGraw-Hill Inc., New York 547–562.
Cited by
Overturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.-N., Finegold, M., & Grompe, M. (1996) · Nature Genetics · doi:10.1038/ng0396-266 · Cited by 549
Mechanisms and consequences of somatic mosaicism in humans
Youssoufian, H., & Pyeritz, R. E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg906 · Cited by 391
Tyrosinaemia type I and NTBC (2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1,3‐cyclohexanedione)
Holme, E., & Lindstedt, S. (1998) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005410820201 · Cited by 264
“In older patients, the low production may in part be due to self-induced correction of the fumarylacetoacetase defect (Kvittingen et al 1993, 1994), which has been documented to occur in nodules of regenerative liver tissue.”
BackgroundMolecular Biology of Fanconi Anemia: Implications for Diagnosis and Therapy
D'Andrea, A. D., & Grompe, M. (1997) · Blood · doi:10.1182/blood.v90.5.1725 · Cited by 194
In Utero Hematopoietic Stem Cell Transplantation: Ontogenic Opportunities and Biologic Barriers
Flake, A. W., & Zanjani, E. D. (1999) · Blood · doi:10.1182/blood.v94.7.2179.419k43_2179_2191 · Cited by 190
Metadata
- Authors
- Kvittingen, E. A., Rootwelt, H., Brandtzaeg, P., Bergan, A., & Berger, R.
- Affiliations
- University of Oslo (NO)
- Oslo University Hospital (NO)
- Venue
- Journal of Clinical Investigation
- Published
- 1993-04-01
- Volume
- 91
- Issue
- 4
- Pages
- 1816-1821
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC288163
- OpenAlex
- W2162704354
- Cited by
- 102
- References
- 20
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 3
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- tyrosinemia type I, liver transplantation, residual enzyme activity, enzyme induction, mosaicism, immunohistochemistry, liver regeneration, enzyme stability, mRNA translation
- MeSH terms
- Amino Acid Metabolism, Inborn Errors, Child, Child, Preschool, Family Health, Fibroblasts, Humans, Hydrolases, Immunohistochemistry, Infant, Liver, Norway, Subcellular Fractions, Tyrosine, Blotting, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hereditary tyrosinemia type I: Self-induced correction of the fumarylacetoacetase defect. https://app.cochat.ai/papers/10.1172/jci116393
- The paper
- Kvittingen, E. A., Rootwelt, H., Brandtzaeg, P., Bergan, A., & Berger, R. (1993). Hereditary tyrosinemia type I: Self-induced correction of the fumarylacetoacetase defect. Journal of Clinical Investigation. https://doi.org/10.1172/jci116393
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.